These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 13809770)

  • 1. [On the vasodilator mechanism of action of beta-pyridylcarbinol].
    CHEVILLARD L; LAURY MC
    C R Hebd Seances Acad Sci; 1960 Jun; 250():4222-4. PubMed ID: 13809770
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of beta-pyridylcarbinol on pulmonary arterial pressure and various indicators of the blood coagulation system in patients with secondary pulmonary hypertension].
    Dubiel JP; Cibor E; Bieron K; Zmuda A; Kostka-Trabka E
    Kardiol Pol; 1988; 31(10):626-32. PubMed ID: 3253452
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacokinetics of a retard preparation of beta-pyridylcarbinol using a new automated assay method].
    Schräpler P; Schulz E; Scholer A
    Med Welt; 1977 Nov; 28(46):1900-3. PubMed ID: 593135
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythrocyte deformability improving action of beta-pyridylcarbinol tartrate.
    Okada T; Okamoto A; Nakamura K
    Experientia; 1981; 37(8):890-2. PubMed ID: 7286147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nicotinic acid, nicotinamide, and pyridylcarbinol in pharmacological dosages on lipid metabolism in humans.
    Zöllner N
    Int J Vitam Nutr Res Suppl; 1989; 30():114-9. PubMed ID: 2529321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Beta-pyridyl-carbinol (Ronicol "Roche") as vasodilator].
    KLAUSGRABER F
    Wien Med Wochenschr; 1950 Nov; 100(45-46):756-8. PubMed ID: 14798850
    [No Abstract]   [Full Text] [Related]  

  • 7. A new vasodilator (roniacol).
    SAMUELS SS; PADERNACHT ED
    Angiology; 1950 Jun; 1(3):236. PubMed ID: 15425860
    [No Abstract]   [Full Text] [Related]  

  • 8. [Circulatory effect of beta-pyridylcarbinol (Ronicol Roche)].
    GATZEK H; MECHELKE K
    Schweiz Med Wochenschr; 1949 Jun; 79(23):526-8. PubMed ID: 18134097
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of beta-pyridylcarbinol (Ronicol Roche) in animal experiments].
    FROMHERZ K
    Schweiz Med Wochenschr; 1949 Jun; 79(23):521. PubMed ID: 18134095
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experience on vasodilation by beta-pyridylcarbinol (Ronicol Roche)].
    THURNHEER A; HELLER H
    Schweiz Med Wochenschr; 1949 Jun; 79(23):522-6. PubMed ID: 18134096
    [No Abstract]   [Full Text] [Related]  

  • 11. [STUDIES ON THE TREATMENT OF ENDOGENOUS HYPERLIPOPROTEINEMIA WITH BETA-PYRIDYL-CARBINOL].
    SCHOEN H; ZELLER W; HENNING N
    Klin Wochenschr; 1963 Nov; 41():1108-9. PubMed ID: 14109876
    [No Abstract]   [Full Text] [Related]  

  • 12. beta-Pyridylcarbinol (Ronicol) releases a prostacyclin-like substance into arterial blood of patients with arteriosclerosis obliterans.
    Dembińska-Kieć A; Korbut R; Bierón K; Kostka-Trabka E; Gryglewski RJ
    Pharmacol Res Commun; 1983 Apr; 15(4):377-85. PubMed ID: 6346344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of beta-pyridylcarbinol (Ronicol) on the myocardial contractility in normal persons.
    Aigner A; Bolzano K; Lisch HJ; Sailer S
    Atherosclerosis; 1974; 20(1):23-5. PubMed ID: 4617580
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on beta-pyridylcarbinol as a precursor of nicotinamide adenine dinucleotide.
    Kizu A; Nakamura T; Kato S; Sawada K; Ijichi H; Kuriyama K
    Jpn J Pharmacol; 1977 Dec; 27(6):817-21. PubMed ID: 204821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition of anabolic effect of methenolone on renal tissue by beta-pyridylcarbinol].
    Schwarzlose W
    Arzneimittelforschung; 1970 Apr; 20(4):481-2. PubMed ID: 5467809
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of hypercholesterolemia with beta-pyridylcarbinol. Experiences after long term treatment over 8 years (author's transl)].
    Zöllner N; Keller C; Wolfram G
    Med Klin; 1976 Apr; 71(18):768-74. PubMed ID: 818496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of nicotinic alcohol timespan tablets in humans by urinary excretion tests.
    DE RITTER E
    Drug Stand; 1960; 28():33-9. PubMed ID: 13814988
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical testing of a combination of clofibrate and beta-pyridylcarbinol in an unusual dosis relation].
    Mann S; Maisenbacher HJ
    Z Allgemeinmed; 1975 Aug; 51(24):1066-71. PubMed ID: 1101545
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of hyperlipidaemia. A comparison of the efficacy of clofibrate and beta-pyridylcarbinol (author's transl)].
    Wolfram G; Keller C; Kilani S; Zöllner N
    Dtsch Med Wochenschr; 1976 Jan; 101(3):76-81. PubMed ID: 1245160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. -Pyridylcarbinol in experimental hypercholesterinemia of the rabbit. Study of lipidic fractions and of the mechanisms of hemostasis.
    Giarola P; Egge H; Gibelli A; Müller J
    Farmaco Sci; 1972 Nov; 27(11):1018-23. PubMed ID: 4647185
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.